CTRI/2024/06/068921尚未招募3 期
A Double Blind Randomized Placebo Controlled Pilot Study Evaluating The Efficacy Of Imeglimin In Patients With Polycystic Ovarian Syndrome - nil
Riya Sharma self0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Polycystic ovarian syndrome diagnosed patient with BMI = 25 kg/m2
- •-Patients willing to give informed consent.
排除标准
- •-History of allergic reactions attributed to compounds of similar chemical or biologic composition of metformin or imeglimin
- •-Patients with history renal dysfunction (documented in biochemical test), acute / chronic metabolic acidosis, congestive cardiac failure needing drug treatment, lactic acidosis
- •-Patients on drug known to have significant drug-drug interactions either metformin or imeglimin
- •-Pregnant females
研究者
相似试验
招募中
不适用
Immunoglobulin therapy in Lung TransplantTransplantationRespiratory - Other respiratory disorders / diseasesACTRN12618001394235The Alfred Hospital40
进行中(未招募)
1 期
Trial of oxytocin for the treatment of emotional withdrawal symptoms and for relapse prevention in abstinent heroin dependent individualsOpioid dependence. The study will be investigating the efficacy of Syntocinon (oxytocin) on treating the withdrawal symptoms and cravings that opioid (e.g. almost always heroin) dependent individuals experience following detoxification.MedDRA version: 20.0 Level: LLT Classification code 10057379 Term: Addiction relapse System Organ Class: 100000004873MedDRA version: 20.0 Level: LLT Classification code 10001126 Term: Addiction any drug System Organ Class: 100000004873EUCTR2014-002708-26-GBniversity of Surrey3
尚未招募
3 期
The Myer Foundation Study into Multiple SclerosisRelapsing remitting multiple sclerosisNeurological - Multiple sclerosisACTRN12606000359538Melbourne Health20
已完成
不适用
A pilot study of D-cycloserine-augmented cognitive behavioural therapy (CBT) with exposure therapy in adolescents with obsessive-compulsive disorder (OCD)Mental and Behavioural DisordersObsessive-compulsive disorderISRCTN70977225Institute of Psychiatry, Kings College London (UK)24
进行中(未招募)
1 期
A randomised double-blind placebo-controlled pilot study of D-cycloserine-augmented exposure therapy in adolescents with obsessive-compulsive disorderEUCTR2008-006947-38-GBKing's College London (Institute of Pyschiatry)24
